$AMBS Recent Headlines 10-Q: AMARANTUS BIOSCIE
Post# of 102473
Posted On: 08/21/2014 12:16:40 PM
$AMBS Recent Headlines
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 4:17 p.m. Aug. 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
Why I'm Still Optimistic On LymPro And Amarantus Bio 10:07 a.m. Aug. 6, 2014 - Seeking Alpha
Amarantus calls warrants and converts debt 5:06 p.m. July 9, 2014 - Seeking Alpha
Behind The Promotion Of Northwest Bio 9:35 a.m. July 7, 2014 - Seeking Alpha
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 5:23 p.m. May 20, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K/A: AMARANTUS BIOSCIENCE HOLDINGS, INC. 6:04 a.m. April 22, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: AMARANTUS BIOSCIENCE HOLDINGS, INC. 6:58 a.m. April 21, 2014 - Edgar Online - (EDG = 10Q, 10K)
Still Several Reasons To Remain Long Amarantus 9:30 a.m. April 9, 2014 - Seeking Alpha
New Cash To Help Drive Amarantus Pipeline 11:13 a.m. Feb. 18, 2014 - Seeking Alpha
What The Amarantus Super Bowl Campaign Can Teach Us About SodaStream 9:36 a.m. Feb. 6, 2014 - Seeking Alpha
Amarantus' ADHD drug performs well in Phase IIa study 10:32 a.m. Feb. 4, 2014 - Seeking Alpha
Amarantus Licenses Phase 2b Ready Eltoprazine For PD-LID 11:19 a.m. Jan. 14, 2014 - Seeking Alpha
An Introduction To Neurotrophic Factors As Treatment For Neurodegenerative Diseases 2:03 p.m. Jan. 7, 2014 - Seeking Alpha
3 Approaches To Retinitis Pigmentosa 11:36 a.m. Jan. 2, 2014 - Seeking Alpha
Amarantus Fundamentals Are Improving 11:27 a.m. Nov. 19, 2013 - Seeking Alpha
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 5:24 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Amarantus' LymPro May Be More Crucial For Alzheimer's Treatment Than We Think 8:38 a.m. Oct. 25, 2013 - Seeking Alpha
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 4:08 p.m. Aug. 19, 2013 - Edgar Online - (EDG = 10Q, 10K)
Initiating Coverage Of Amarantus - Credibility vs. Perception - Analyst Blog 1:10 p.m. May 23, 2013 - Zacks.com
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 11:27 a.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
Amarantus to Present at Upcoming Investor Conferences 8:42 a.m. Aug. 19, 2014 - GlobeNewswire
Amarantus Exercises Option to License Intellectual Property From University of Miami Bascom Palmer Eye Institute for Use of MANF in Retinal Disorders 8:11 a.m. Aug. 15, 2014 - GlobeNewswire
Amarantus BioScience Holdings, Inc. "Preparing Amarantus for the Up-list in 2H-14: Capital Markets Strategy" 8:03 a.m. Aug. 11, 2014 - ACCESSWIRE
Amarantus Enters Into Research Collaboration With the Buck Institute for Research on Aging for MANF 8:01 a.m. Aug. 11, 2014 - GlobeNewswire
OTC Trading Stock News: Amarantus Biosciences Holdings, Inc. Virtus Oil and Gas Corp, Cannabis Sativa, Inc. Creative Edge Nutrition, Inc. DNA Brands, Inc. 8:00 a.m. Aug. 5, 2014 - PR Newswire - PRF
Amarantus BioScience Holdings, Inc. - "#C4CT Wrap-up and the Decision to Present Interim LP-002 Data" 4:26 p.m. Aug. 4, 2014 - ACCESSWIRE
#C4CT Summit Explored Emerging Theories on Traumatic Brain Injury, Chronic Traumatic Encephalopathy and Possible Links to Alzheimer's Disease 8:00 a.m. Aug. 4, 2014 - GlobeNewswire
Cerora, Inc. Announces Second Close in Seed Round of Financing 11:15 a.m. Aug. 1, 2014 - ACCESSWIRE
Amarantus Announces Positive Top-Line Interim Clinical Data for Alzheimer's Blood Diagnostic LymPro Test(R) 9:25 a.m. Aug. 1, 2014 - GlobeNewswire
Amarantus Acquires Exclusive Option to License Alzheimer's Therapeutic IP of Dr. Thomas Arendt From University of Leipzig 8:01 a.m. Aug. 1, 2014 - GlobeNewswire
The 3rd Alzheimer's-Focused #C4CT Concussion Summit Convenes Today at the United Nations 10:48 a.m. July 31, 2014 - GlobeNewswire
Amarantus Amends LymPro LP-002 Clinical Protocol to Report Interim Data at #C4CT Presentation 8:01 a.m. July 30, 2014 - GlobeNewswire
Registration for the 3rd Alzheimer's-Focused #C4CT Summit Has Closed Due to Overwhelming Interest 8:01 a.m. July 30, 2014 - GlobeNewswire
Sidney Rice and Ben Utecht Talk to NFL Network's Andrea Kremer and ESPN's Andrew Brandt at Upcoming #C4CT Concussion Awareness Summit at the United Nations 3:17 p.m. July 28, 2014 - GlobeNewswire
Amarantus Appoints Donald D. Huffman to Board of Directors 8:10 a.m. July 28, 2014 - GlobeNewswire
Amarantus and BSI Announce Dr. Thomas Arendt as Presenter at 3rd Alzheimer's Focused #C4CT Concussion Awareness Summit at United Nations 11:34 a.m. July 23, 2014 - GlobeNewswire
Amarantus and BSI Proudly Announce BIO CEO & President Jim Greenwood as Panelist for 3rd Alzheimer's Focused #C4CT Concussion Awareness Summit at United Nations 3:47 p.m. July 22, 2014 - GlobeNewswire
Amarantus Discusses New Independent Peer-Reviewed Research Papers on MANF 7:50 a.m. July 18, 2014 - GlobeNewswire
Amarantus BioScience Holdings, Inc. - "Understanding Data Presented at AAIC and Why Amarantus is Well Positioned Heading into #C4CT" 2:00 p.m. July 17, 2014 - ACCESSWIRE
Amarantus and BSI Announce Continued Support of One Mind at the 3rd #C4CT Concussion Awareness Summit at the United Nations 8:01 a.m. July 17, 2014 - GlobeNewswire
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 4:17 p.m. Aug. 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
Why I'm Still Optimistic On LymPro And Amarantus Bio 10:07 a.m. Aug. 6, 2014 - Seeking Alpha
Amarantus calls warrants and converts debt 5:06 p.m. July 9, 2014 - Seeking Alpha
Behind The Promotion Of Northwest Bio 9:35 a.m. July 7, 2014 - Seeking Alpha
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 5:23 p.m. May 20, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K/A: AMARANTUS BIOSCIENCE HOLDINGS, INC. 6:04 a.m. April 22, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: AMARANTUS BIOSCIENCE HOLDINGS, INC. 6:58 a.m. April 21, 2014 - Edgar Online - (EDG = 10Q, 10K)
Still Several Reasons To Remain Long Amarantus 9:30 a.m. April 9, 2014 - Seeking Alpha
New Cash To Help Drive Amarantus Pipeline 11:13 a.m. Feb. 18, 2014 - Seeking Alpha
What The Amarantus Super Bowl Campaign Can Teach Us About SodaStream 9:36 a.m. Feb. 6, 2014 - Seeking Alpha
Amarantus' ADHD drug performs well in Phase IIa study 10:32 a.m. Feb. 4, 2014 - Seeking Alpha
Amarantus Licenses Phase 2b Ready Eltoprazine For PD-LID 11:19 a.m. Jan. 14, 2014 - Seeking Alpha
An Introduction To Neurotrophic Factors As Treatment For Neurodegenerative Diseases 2:03 p.m. Jan. 7, 2014 - Seeking Alpha
3 Approaches To Retinitis Pigmentosa 11:36 a.m. Jan. 2, 2014 - Seeking Alpha
Amarantus Fundamentals Are Improving 11:27 a.m. Nov. 19, 2013 - Seeking Alpha
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 5:24 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Amarantus' LymPro May Be More Crucial For Alzheimer's Treatment Than We Think 8:38 a.m. Oct. 25, 2013 - Seeking Alpha
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 4:08 p.m. Aug. 19, 2013 - Edgar Online - (EDG = 10Q, 10K)
Initiating Coverage Of Amarantus - Credibility vs. Perception - Analyst Blog 1:10 p.m. May 23, 2013 - Zacks.com
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 11:27 a.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
Amarantus to Present at Upcoming Investor Conferences 8:42 a.m. Aug. 19, 2014 - GlobeNewswire
Amarantus Exercises Option to License Intellectual Property From University of Miami Bascom Palmer Eye Institute for Use of MANF in Retinal Disorders 8:11 a.m. Aug. 15, 2014 - GlobeNewswire
Amarantus BioScience Holdings, Inc. "Preparing Amarantus for the Up-list in 2H-14: Capital Markets Strategy" 8:03 a.m. Aug. 11, 2014 - ACCESSWIRE
Amarantus Enters Into Research Collaboration With the Buck Institute for Research on Aging for MANF 8:01 a.m. Aug. 11, 2014 - GlobeNewswire
OTC Trading Stock News: Amarantus Biosciences Holdings, Inc. Virtus Oil and Gas Corp, Cannabis Sativa, Inc. Creative Edge Nutrition, Inc. DNA Brands, Inc. 8:00 a.m. Aug. 5, 2014 - PR Newswire - PRF
Amarantus BioScience Holdings, Inc. - "#C4CT Wrap-up and the Decision to Present Interim LP-002 Data" 4:26 p.m. Aug. 4, 2014 - ACCESSWIRE
#C4CT Summit Explored Emerging Theories on Traumatic Brain Injury, Chronic Traumatic Encephalopathy and Possible Links to Alzheimer's Disease 8:00 a.m. Aug. 4, 2014 - GlobeNewswire
Cerora, Inc. Announces Second Close in Seed Round of Financing 11:15 a.m. Aug. 1, 2014 - ACCESSWIRE
Amarantus Announces Positive Top-Line Interim Clinical Data for Alzheimer's Blood Diagnostic LymPro Test(R) 9:25 a.m. Aug. 1, 2014 - GlobeNewswire
Amarantus Acquires Exclusive Option to License Alzheimer's Therapeutic IP of Dr. Thomas Arendt From University of Leipzig 8:01 a.m. Aug. 1, 2014 - GlobeNewswire
The 3rd Alzheimer's-Focused #C4CT Concussion Summit Convenes Today at the United Nations 10:48 a.m. July 31, 2014 - GlobeNewswire
Amarantus Amends LymPro LP-002 Clinical Protocol to Report Interim Data at #C4CT Presentation 8:01 a.m. July 30, 2014 - GlobeNewswire
Registration for the 3rd Alzheimer's-Focused #C4CT Summit Has Closed Due to Overwhelming Interest 8:01 a.m. July 30, 2014 - GlobeNewswire
Sidney Rice and Ben Utecht Talk to NFL Network's Andrea Kremer and ESPN's Andrew Brandt at Upcoming #C4CT Concussion Awareness Summit at the United Nations 3:17 p.m. July 28, 2014 - GlobeNewswire
Amarantus Appoints Donald D. Huffman to Board of Directors 8:10 a.m. July 28, 2014 - GlobeNewswire
Amarantus and BSI Announce Dr. Thomas Arendt as Presenter at 3rd Alzheimer's Focused #C4CT Concussion Awareness Summit at United Nations 11:34 a.m. July 23, 2014 - GlobeNewswire
Amarantus and BSI Proudly Announce BIO CEO & President Jim Greenwood as Panelist for 3rd Alzheimer's Focused #C4CT Concussion Awareness Summit at United Nations 3:47 p.m. July 22, 2014 - GlobeNewswire
Amarantus Discusses New Independent Peer-Reviewed Research Papers on MANF 7:50 a.m. July 18, 2014 - GlobeNewswire
Amarantus BioScience Holdings, Inc. - "Understanding Data Presented at AAIC and Why Amarantus is Well Positioned Heading into #C4CT" 2:00 p.m. July 17, 2014 - ACCESSWIRE
Amarantus and BSI Announce Continued Support of One Mind at the 3rd #C4CT Concussion Awareness Summit at the United Nations 8:01 a.m. July 17, 2014 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼